A new AI tool called DeepGlioma aims to give surgeons a real-time way to test brain tumors for genetic mutations during surgery.April 7, 2023Check out STAT+Sponsored By Adobe STAT+ | A new AI tool aims to help surgeons quickly analyze brain tumor mutations during surgery A new AI tool called DeepGlioma aims to dramatically speed up the process of testing brain tumors called gliomas for genetic mutations. By Brittany Trang STAT+ | To make immunotherapy safe for brain tumors, researchers will have to tackle new risks The initial swelling from CAR-T therapy is found to hold potentially lethal dangers in treating tumors of the brain or spinal cord. By Angus Chen STAT+ | Cancer drug shortages have plagued the U.S. for years. Can they be fixed? Persistent shortages of cancer drugs arise in part from the highly globalized, yet mostly opaque, pharmaceutical supply chain. By Jill Neimark More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Cancer Briefing? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments